Lysozyme (Muramidase) Test (26)
🧪 Lysozyme (Muramidase) Test — Complete Guide
An Antimicrobial Enzyme Elevated in Infection, Inflammation, and Hematologic Disorders
Lysozyme (muramidase) is an antibacterial enzyme that breaks down the peptidoglycan layer of bacterial cell walls. It is produced primarily by neutrophils, monocytes, macrophages, salivary glands, and lacrimal glands.
Serum lysozyme levels increase in disorders involving monocyte/macrophage proliferation, granulomatous inflammation, and chronic infections, making it a useful adjunctive biomarker in selected clinical situations.
1️⃣ Purpose of the Lysozyme Test
✔ 1) Evaluation of Hematologic Disorders
Lysozyme is highly elevated in conditions with monocyte proliferation, especially:
- AML M4 (acute myelomonocytic leukemia)
- AML M5 (acute monocytic leukemia)
- Other disorders involving monocytosis
It is often used as a supportive marker together with peripheral smear, differential count, and bone marrow examination.
✔ 2) Assessment of Granulomatous and Chronic Inflammatory Diseases
Lysozyme levels rise in diseases characterized by granuloma formation:
- Sarcoidosis (elevated along with ACE)
- Tuberculosis
- Wegener’s granulomatosis
- Chronic inflammatory bowel disease (IBD)
It is not diagnostic alone, but helps in the overall inflammatory profile of the patient.
✔ 3) Supportive Evaluation of Renal and Tissue Injury
Because lysozyme is excreted via the kidneys:
- Levels may increase in reduced renal function
- Must be interpreted with creatinine and eGFR
It is rarely used as a standalone indicator of renal disease.
2️⃣ Test Method
✔ Turbidimetric Assay (Most Common Method)
The turbidimetric method measures lysozyme activity by assessing the rate at which the enzyme lyses bacterial cell walls.
🔬 Principle
- The reagent contains Micrococcus lysodeikticus cell wall substrate.
- Lysozyme in the sample breaks down the peptidoglycan, causing reduced turbidity.
- The rate of turbidity decrease is measured photometrically and converted into enzyme activity.
🔧 Important Considerations
- Hemolysis or lipemia can interfere with optical readings.
- Temperature and pH must be strictly controlled (25–37°C).
- Renal impairment elevates results due to reduced clearance.
3️⃣ Reference Range
Typical adult serum lysozyme reference interval:
5.0 – 10.2 μg/mL
(Varies by laboratory and assay manufacturer)
4️⃣ Clinical Significance
Lysozyme is elevated in a broad range of conditions:
- Infection
- Inflammation
- Granulomatous disease
- Leukemia (monocytic lineage)
- Renal dysfunction
Its greatest value is in monocytic leukemias and granulomatous disorders.
5️⃣ Conditions Associated With Increased Lysozyme (↑)
🔥 1) Hematologic Diseases
Most characteristic cause of marked elevation:
- AML M4 (acute myelomonocytic leukemia)
- AML M5 (acute monocytic leukemia)
Monocyte expansion → high lysozyme secretion.
🔥 2) Granulomatous Diseases
- Sarcoidosis
- Tuberculosis
- Granulomatosis with polyangiitis
- Other chronic granulomatous conditions
Often elevated together with ACE.
🔥 3) Inflammatory Bowel Disease
- Crohn’s disease
- Severe chronic gastrointestinal inflammation
🔥 4) Infectious Diseases
- Bacterial infections
- Systemic inflammatory states (sepsis)
- Some viral infections
🔥 5) Kidney Diseases
Due to reduced renal clearance:
- Acute kidney injury
- Chronic kidney failure
6️⃣ Conditions Associated With Decreased Lysozyme (↓)
Although less clinically important, low levels may occur in:
- Severe immunosuppression
- Neutropenia or monocytopenia
- Certain immunodeficiency disorders
- Malnutrition or chronic wasting conditions
7️⃣ Interpretation Considerations
- Never used as a standalone diagnostic test
- In hematologic disorders → interpret with CBC, differential, smear, and bone marrow findings
- In granulomatous disease → interpret with ACE, imaging, and clinical features
- In kidney disease → always check creatinine/eGFR
- Consider assay interference from hemolysis, lipemia, or poor sample quality
🧫 Urine Microscopy: complete guide (26) – MedLab Insight
8️⃣ Summary Table
| Category | Details |
|---|---|
| Test Name | Lysozyme (Muramidase) |
| Purpose | Evaluation of monocytic leukemias, granulomatous diseases, chronic inflammation |
| Method | Turbidimetric assay |
| Reference Range | ~5.0–10.2 μg/mL |
| Increased In | AML-M4/M5, sarcoidosis, TB, IBD, infections, renal impairment |
| Decreased In | Immunosuppression, monocytopenia |
| Key Interpretation Point | Adjunctive marker; must be interpreted with clinical/lab context |
9️⃣ References
- Henry’s Clinical Diagnosis and Management by Laboratory Methods, 24th ed.
- Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th ed.
- Am J Hematol. Clinical utility of serum lysozyme in hematologic malignancies.
- Chest. Serum lysozyme levels in sarcoidosis.
- Clin Chest Med. Laboratory evaluation of granulomatous diseases.